C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/70 (2006.01)
Patent
CA 2411401
This invention relates to antiviral drug susceptibility and resistance tests to be used in identifying effective drug regimens for the treatment of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) and further relates to the means and methods of monitoring the clinical progression of HIV infection and its response to antiretroviral therapy, particularly nucleoside reverse transcriptase inhibitor therapy using phenotypic susceptibility assays or genotypic assays.
L'invention concerne des essais de résistance et de susceptibilité aux médicaments antiviraux destinés à être utilisés pour l'identification de régimes posologiques efficaces dans le traitement de l'infection par le virus de l'immunodéficience humaine (VIH) et du syndrome d'immunodéficience acquis (SIDA). L'invention concerne en outre des systèmes et des procédés pour le contrôle de la progression clinique de l'infection par le VIH et de sa réponse à la thérapie antirétrovirale, en particulier la thérapie par inhibiteur de transcriptase inverse de nucléoside fondée sur des essais de susceptibilité phénotypique ou des essais génotypiques.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Virologic Inc.
LandOfFree
Means and methods for monitoring antiretroviral therapy and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Means and methods for monitoring antiretroviral therapy and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Means and methods for monitoring antiretroviral therapy and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1645733